Centaurus Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.35M | Sell |
13,295
-236
| -2% | -$50.8K | 0.13% | 172 |
|
|
2026
Q1 | $2.94M | Sell |
13,531
-24
| -0.2% | -$5.32K | 0.14% | 150 |
|
|
2025
Q4 | $3.1M | Buy |
13,555
+237
| +2% | +$54K | 0.14% | 149 |
|
|
2025
Q3 | $3.08M | Buy |
13,318
+4,821
| +57% | +$982K | 0.14% | 145 |
|
|
2025
Q2 | $1.58M | Sell |
8,497
-134
| -2% | -$24.9K | 0.09% | 217 |
|
|
2025
Q1 | $1.81M | Buy |
8,631
+124
| +1% | +$24.1K | 0.11% | 180 |
|
|
2024
Q4 | $1.51M | Buy |
8,507
+188
| +2% | +$34.6K | 0.09% | 206 |
|
|
2024
Q3 | $1.64M | Buy |
8,319
+1,199
| +17% | +$224K | 0.1% | 183 |
|
|
2024
Q2 | $1.22M | Sell |
7,120
-215
| -3% | -$35.6K | 0.08% | 217 |
|
|
2024
Q1 | $1.34M | Sell |
7,335
-301
| -4% | -$51.9K | 0.09% | 196 |
|
|
2023
Q4 | $1.18M | Sell |
7,636
-863
| -10% | -$126K | 0.09% | 215 |
|
|
2023
Q3 | $1.27M | Buy |
8,499
+399
| +5% | +$58.6K | 0.11% | 186 |
|
|
2023
Q2 | $1.09M | Sell |
8,100
-6,404
| -44% | -$939K | 0.1% | 218 |
|
|
2023
Q1 | $2.31M | Buy |
14,504
+941
| +7% | +$144K | 0.19% | 131 |
|
|
2022
Q4 | $2.19M | Sell |
13,563
-876
| -6% | -$134K | 0.21% | 126 |
|
|
2022
Q3 | $1.94M | Buy |
14,439
+667
| +5% | +$95.7K | 0.19% | 141 |
|
|
2022
Q2 | $2.11M | Sell |
13,772
-3,852
| -22% | -$589K | 0.21% | 128 |
|
|
2022
Q1 | $2.86M | Sell |
17,624
-68
| -0.4% | -$9.88K | 0.23% | 115 |
|
|
2021
Q4 | $2.4M | Buy |
17,692
+2,174
| +14% | +$257K | 0.18% | 148 |
|
|
2021
Q3 | $1.67M | Buy |
15,518
+118
| +0.8% | +$13.5K | 0.14% | 180 |
|
|
2021
Q2 | $1.74M | Buy |
15,400
+3,082
| +25% | +$347K | 0.15% | 172 |
|
|
2021
Q1 | $1.33M | Buy |
12,318
+3,769
| +44% | +$403K | 0.13% | 188 |
|
|
2020
Q4 | $916K | Sell |
8,549
-710
| -8% | -$68.2K | 0.1% | 248 |
|
|
2020
Q3 | $811K | Sell |
9,259
-1,170
| -11% | -$110K | 0.11% | 202 |
|
|
2020
Q2 | $1.02M | Buy |
10,429
+2,201
| +27% | +$194K | 0.15% | 168 |
|
|
2020
Q1 | $627K | Buy |
8,228
+4,058
| +97% | +$346K | 0.13% | 188 |
|
|
2019
Q4 | $369K | Buy |
+4,170
| New | +$346K | 0.05% | 353 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$105K | – | 471 |
|
|
2018
Q3 | $105K | Sell |
1,000
-12,746
| -93% | -$1.21M | 0.02% | 514 |
|
|
2018
Q2 | $1.27M | Buy |
13,746
+12,130
| +751% | +$1.18M | 0.18% | 126 |
|
|
2018
Q1 | $153K | Buy |
+1,616
| New | +$178K | 0.04% | 365 |
|
Other funds holding ABBV
Centaurus Financial's ABBV Position: Q2 2026 in Review
Centaurus Financial reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $50.8K and leaving 13,295 shares worth $3.35M. The position accounts for 0.13% of the portfolio, ranked #172.
Centaurus Financial first reported a position in ABBV in Q1 2018 and has held it in 30 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Centaurus Financial held 13,295 shares of AbbVie worth $3.35M as of Q2 2026.
- Centaurus Financial sold 236 AbbVie shares in Q2 2026, an estimated $50.8K.
- AbbVie made up 0.13% of Centaurus Financial's portfolio in Q2 2026, its #172 holding.
- Centaurus Financial first reported a position in AbbVie in Q1 2018 and has held it in 30 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.